UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Ultragenyx Pharmaceutical
RARE
$2.49B
| $13.7M | ﹤0.01% |
325,651
+232,582
| +250% | +$11.5M |
|
2727
Prosperity Bancshares
PB
$8.94B
| $13.7M | ﹤0.01% |
181,719
+111,618
| +159% | +$8.62M |
|
2728
BlackBerry
BB
$5.24B
| $13.7M | ﹤0.01% |
3,617,380
+3,181,530
| +730% | +$8.45M |
|
2729
Gildan
GIL
$10.8B
| $13.7M | ﹤0.01% |
290,615
+163,788
| +129% | +$7.89M |
|
2730
CALL
On Holding
ONON
$12.5B
| $13.7M | ﹤0.01% |
249,377
+13,534
| +6% | +$717K |
|
2731
CVR Energy
CVI
$3.18B
| $13.7M | ﹤0.01% |
728,447
+629,785
| +638% | +$12.7M |
|
2732
John Wiley & Sons Class A
WLY
$2.74B
| $13.6M | ﹤0.01% |
311,717
+195,671
| +169% | +$9.6M |
|
2733
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.58B
| $13.6M | ﹤0.01% |
612,119
+51,102
| +9% | +$1.2M |
|
2734
Syndax Pharmaceuticals
SNDX
$1.75B
| $13.6M | ﹤0.01% |
1,028,821
+882,383
| +603% | +$15.1M |
|
2735
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $13.5M | ﹤0.01% |
273,476
+222,655
| +438% | +$11.3M |
|
2736
AMN Healthcare
AMN
$1.23B
| $13.5M | ﹤0.01% |
564,594
+456,812
| +424% | +$14.5M |
|
2737
Invesco BuyBack Achievers ETF
PKW
$1.75B
| $13.5M | ﹤0.01% |
117,085
-3,431
| -3% | -$406K |
|
2738
Angel Oak Income ETF
CARY
$1.39B
| $13.5M | ﹤0.01% |
653,332
+345,310
| +112% | +$7.21M |
|
|
DSL
2739
DoubleLine Income Solutions Fund
DSL
$1.23B
| $13.4M | ﹤0.01% |
1,065,826
+51,864
| +5% | +$659K |
|
2740
Helix Energy Solutions
HLX
$1.48B
| $13.4M | ﹤0.01% |
1,435,654
+1,209,987
| +536% | +$12.2M |
|
2741
Stantec
STN
$8.34B
| $13.4M | ﹤0.01% |
170,175
+25,422
| +18% | +$2.11M |
|
2742
State Street SPDR S&P Capital Markets ETF
KCE
$468M
| $13.3M | ﹤0.01% |
96,891
+12,370
| +15% | +$1.71M |
|
2743
ICU Medical
ICUI
$4.14B
| $13.3M | ﹤0.01% |
85,897
+57,292
| +200% | +$9.69M |
|
2744
American Eagle Outfitters
AEO
$2.97B
| $13.3M | ﹤0.01% |
799,545
+669,010
| +513% | +$12.7M |
|
2745
iShares Micro-Cap ETF
IWC
$1.5B
| $13.3M | ﹤0.01% |
102,222
+39,068
| +62% | +$5.09M |
|
2746
Kulicke & Soffa
KLIC
$4.85B
| $13.3M | ﹤0.01% |
285,544
+222,065
| +350% | +$10.4M |
|
2747
CALL
Robinhood
HOOD
$82.4B
| $13.3M | ﹤0.01% |
357,540
+288,640
| +419% | +$9.32M |
|
2748
Yeti Holdings
YETI
$4B
| $13.3M | ﹤0.01% |
345,748
+248,222
| +255% | +$9.86M |
|
2749
First Hawaiian
FHB
$3.37B
| $13.3M | ﹤0.01% |
512,480
+291,971
| +132% | +$7.51M |
|
2750
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.7B
| $13.3M | ﹤0.01% |
231,829
+28,886
| +14% | +$1.69M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.